Электронный архив

Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis

Показать сокращенную информацию

dc.contributor.author Rubio K.
dc.contributor.author Singh I.
dc.contributor.author Dobersch S.
dc.contributor.author Sarvari P.
dc.contributor.author Günther S.
dc.contributor.author Cordero J.
dc.contributor.author Mehta A.
dc.contributor.author Wujak L.
dc.contributor.author Cabrera-Fuentes H.
dc.contributor.author Chao C.
dc.contributor.author Braubach P.
dc.contributor.author Bellusci S.
dc.contributor.author Seeger W.
dc.contributor.author Günther A.
dc.contributor.author Preissner K.
dc.contributor.author Wygrecka M.
dc.contributor.author Savai R.
dc.contributor.author Papy-Garcia D.
dc.contributor.author Dobreva G.
dc.contributor.author Heikenwalder M.
dc.contributor.author Savai-Pullamsetti S.
dc.contributor.author Braun T.
dc.contributor.author Barreto G.
dc.date.accessioned 2020-01-15T22:01:20Z
dc.date.available 2020-01-15T22:01:20Z
dc.date.issued 2019
dc.identifier.uri https://dspace.kpfu.ru/xmlui/handle/net/156517
dc.description.abstract © 2019, The Author(s). Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and highly lethal lung disease with unknown etiology and poor prognosis. IPF patients die within 2 years after diagnosis mostly due to respiratory failure. Current treatments against IPF aim to ameliorate patient symptoms and to delay disease progression. Unfortunately, therapies targeting the causes of or reverting IPF have not yet been developed. Here we show that reduced levels of miRNA lethal 7d (MIRLET7D) in IPF compromise epigenetic gene silencing mediated by the ribonucleoprotein complex MiCEE. In addition, we find that hyperactive EP300 reduces nuclear HDAC activity and interferes with MiCEE function in IPF. Remarkably, EP300 inhibition reduces fibrotic hallmarks of in vitro (patient-derived primary fibroblast), in vivo (bleomycin mouse model), and ex vivo (precision-cut lung slices, PCLS) IPF models. Our work provides the molecular basis for therapies against IPF using EP300 inhibition.
dc.title Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
dc.type Article
dc.relation.ispartofseries-issue 1
dc.relation.ispartofseries-volume 10
dc.collection Публикации сотрудников КФУ
dc.source.id SCOPUS-2019-10-1-SID85066018298


Файлы в этом документе

Данный элемент включен в следующие коллекции

  • Публикации сотрудников КФУ Scopus [24551]
    Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.

Показать сокращенную информацию

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись

Статистика